Bank of New York Mellon’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.03M | Sell |
189,663
-12,248
| -6% | -$196K | ﹤0.01% | 2533 |
|
|
2025
Q1 | $3.45M | Sell |
201,911
-1,150
| -0.6% | -$19.7K | ﹤0.01% | 2408 |
|
|
2024
Q4 | $5.03M | Buy |
203,061
+62
| +0% | +$1.54K | ﹤0.01% | 2284 |
|
|
2024
Q3 | $5.79M | Sell |
202,999
-47,340
| -19% | -$1.35M | ﹤0.01% | 2221 |
|
|
2024
Q2 | $6.61M | Buy |
250,339
+27,960
| +13% | +$738K | ﹤0.01% | 2185 |
|
|
2024
Q1 | $7.19M | Sell |
222,379
-22,451
| -9% | -$725K | ﹤0.01% | 2144 |
|
|
2023
Q4 | $10.3M | Buy |
244,830
+52,616
| +27% | +$2.22M | ﹤0.01% | 1975 |
|
|
2023
Q3 | $7.38M | Buy |
192,214
+9,648
| +5% | +$370K | ﹤0.01% | 2122 |
|
|
2023
Q2 | $3.46M | Buy |
182,566
+13,492
| +8% | +$256K | ﹤0.01% | 2526 |
|
|
2023
Q1 | $2.62M | Buy |
169,074
+1,564
| +0.9% | +$24.3K | ﹤0.01% | 2642 |
|
|
2022
Q4 | $2.97M | Buy |
167,510
+17,836
| +12% | +$317K | ﹤0.01% | 2628 |
|
|
2022
Q3 | $835K | Buy |
149,674
+8,241
| +6% | +$46K | ﹤0.01% | 3294 |
|
|
2022
Q2 | $552K | Sell |
141,433
-5,366
| -4% | -$20.9K | ﹤0.01% | 3528 |
|
|
2022
Q1 | $809K | Buy |
146,799
+933
| +0.6% | +$5.14K | ﹤0.01% | 3439 |
|
|
2021
Q4 | $1.24M | Buy |
145,866
+5,393
| +4% | +$46K | ﹤0.01% | 3260 |
|
|
2021
Q3 | $1.22M | Buy |
140,473
+17,605
| +14% | +$153K | ﹤0.01% | 3285 |
|
|
2021
Q2 | $1.3M | Sell |
122,868
-26,082
| -18% | -$276K | ﹤0.01% | 3253 |
|
|
2021
Q1 | $2.39M | Sell |
148,950
-18,161
| -11% | -$291K | ﹤0.01% | 2827 |
|
|
2020
Q4 | $7.72M | Buy |
167,111
+12,665
| +8% | +$585K | ﹤0.01% | 2140 |
|
|
2020
Q3 | $5.43M | Buy |
154,446
+79,342
| +106% | +$2.79M | ﹤0.01% | 2169 |
|
|
2020
Q2 | $1.83M | Buy |
+75,104
| New | +$1.83M | ﹤0.01% | 2737 |
|